APA (7th ed.) Citation

Hecht, M., Meier, F., Zimmer, L., Polat, B., Loquai, C., Weishaupt, C., . . . Heinzerling, L. (2018). Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients. British journal of cancer, 118(6), . https://doi.org/10.1038/bjc.2017.489

Chicago Style (17th ed.) Citation

Hecht, Markus, et al. "Clinical Outcome of Concomitant Vs Interrupted BRAF Inhibitor Therapy During Radiotherapy in Melanoma Patients." British Journal of Cancer 118, no. 6 (2018). https://doi.org/10.1038/bjc.2017.489.

MLA (9th ed.) Citation

Hecht, Markus, et al. "Clinical Outcome of Concomitant Vs Interrupted BRAF Inhibitor Therapy During Radiotherapy in Melanoma Patients." British Journal of Cancer, vol. 118, no. 6, 2018, https://doi.org/10.1038/bjc.2017.489.